GlobeNewswire

New MindManager 11 for Mac: Visually Capture, Organize, and Share Information to Drive Project and Business Success

Dela

Powerful mind mapping and information visualization software introduces its most robust Mac version yet; complete with new diagram types, an expanded template library, advanced mapping capabilities, and improved sharing options

 

OTTAWA, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Introduced today, MindManager® 11 for Mac brings new elegance and efficiency to the way individuals and teams organize ideas, tackle tasks, and achieve their goals. Already a leader in mind mapping and information visualization on the Mac, MindManager's new release offers advanced mapping capabilities, new diagram types and templates, and easy ways to share and publish your work - all delivered within a redesigned interface optimized to enhance productivity.

Individuals, small businesses, and global organizations rely upon MindManager to efficiently brainstorm and organize ideas, communicate knowledge effectively, and execute project success. MindManager enables users to turn unstructured ideas and information into dynamic mind maps, timelines, flowcharts, and more, so they can streamline efforts, supercharge productivity, and pre-emptively reveal risks and opportunities.

"MindManager 11 for Mac offers powerful ways to visualize data, making it possible to unlock the potential of your organization's information, strategies, and plans," said Michael Deutch, Vice President of Products for MindManager. "When 77 percent of respondents to a recent MindManager workplace survey told us their organizations were seeing poor productivity and failed projects because not enough time is spent on ensuring alignment, it was clear that businesses need to adopt better ways to define common goals and get their teams behind them."

"MindManager is an essential tool to do just that. And with this new release, we're delivering a robust application that leverages our team's 20 years of information-visualization expertise to bring Mac users the capabilities they need to take control of their work and world," added Deutch.  

MindManager 11 for Mac is packed with more power and possibility with updates including:

  • NEW!  Visualize paths to growth and profit with the expanded template library
    More than a dozen new and improved templates and diagram formats will help users see ideas, plans, and possibilities in ways that empower bigger thinking, smarter decisions, and better outcomes. Timelines, workflow diagrams, and concept maps illuminate correct paths and drive efficient action; Venn, onion, and swim lane diagrams give a clearer understanding of relationships and intersections; and customizable matrices empower users to correlate ideas and quickly assess risk, reward, value, and priority.
  • NEW! Reinvent the way you use MindManager with Digital Architect
    With the expanded library of background objects and map-making capabilities, existing templates can be customized with shapes, images, text boxes, swim lanes, dividers, and more to clarify relationships and accountability, or whole new structures can be built to organize and understand the big picture. Now users have free rein over the way their map looks, the story it tells, and the results it helps achieve.
  • NEW! Work more efficiently and effectively with advanced mapping capabilities
    With advanced mapping features and task management tools, maps and diagrams are easier to work with, tell a more robust story, and drive better outcomes - faster than ever. Now multiple maps can be opened in a single application for easy multitasking; data can be rolled up from multiple maps into a single dashboard for at-a-glance understanding; multiple external links can be added to a single topic to create a one-stop resource repository; link titles can be customized for instant context, and more. 
  • NEW! Publish and share maps easily with anyone, anywhere
    Users can now introduce a new level of polish, professionalism, and impact into the map viewing experience with the Interactive HTML5 Presentation Export. Clear, simple controls make navigation effortless, even for novice recipients, and keep their focus on the map's substance, not its structure. And the new Publish tool makes it quick and easy for users to share brainstorms with colleagues, show proposals and plans to customers, or publish MindManager content to the web for others to learn from and build on.
  • NEW! Built natively for Mac, compatible with your entire organization
    Designed to take advantage of the power of High Sierra, version 11 is MindManager's biggest Mac update yet, loaded with new features. This release assures that anyone in a business - whether they're running Mac or Windows - can use the power of the latest diagramming styles and advanced mapping capabilities to achieve alignment and project success. Plus, with Readers for Mac and Windows available to MindManager Enterprise customers, maps can be shared with everyone on the team, even if they don't have the full MindManager software installed.

Pricing and Availability
MindManager 11 for Mac is available now in English, French, and German as an individual license for $179.00 (USD) / £178.80 / €213.01 suggested retail price (SRP). Upgrade pricing for the individual license is $89.00 (USD) / £90.00 / €105.91 SRP. UK and European prices are inclusive of VAT.

MindManager 11 for Mac is also available as part of MindManager Enterprise, available for teams with five licenses and more.

MindManager Workplace Survey
For more information on the MindManager Workplace Survey or to download the survey report, please visit www.mindjet.com/workplace-productivity-and-planning-report/
   
About MindManager
Mindjet's MindManager helps individuals, teams, and enterprises do great work faster by simplifying the way they capture, organize, and share information. Transforming scattered ideas and unstructured data into dynamic visual maps, MindManager gives people a clearer understanding and greater control over their time, work, and world. Millions of global users choose MindManager to brainstorm ideas, plan and execute projects, and communicate knowledge. Mindjet is a division of Corel Corporation. For more information, please visit www.mindjet.com.

© 2018 Corel Corporation. All rights reserved. Corel, MindManager, the MindManager logo, and Mindjet are trademarks or registered trademarks of Corel Corporation and/or its subsidiaries in Canada, the U.S., and elsewhere. All other trademarks mentioned herein are the property of their respective owners. Patents: www.corel.com/patent

Media Contact
Lucy Screnci
lucy.screnci@corel.com
www.mindjet.com

Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/3b6f8f89-8c82-4b5f-bbec-66862fb90f08 http://www.globenewswire.com/NewsRoom/AttachmentNg/c9465077-ef03-4ea8-9a69-8adb53064522 http://www.globenewswire.com/NewsRoom/AttachmentNg/6478c4f0-b97a-468c-b155-58566ede22d7 http://www.globenewswire.com/NewsRoom/AttachmentNg/f2e8f08d-631a-4316-ba26-5656b1b360c8

A video accompanying this release is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/05ef6ed2-8e0a-4391-9730-187c8bcd55bf




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Corel via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum